Fasting hyperglycemia impairs glucose- but not insulin-mediated suppression of glucagon secretion

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 5, 2007, Pages 1778-1784

  Abdul Ghani, Muhammad ^a,b   DeFronzo, Ralph A ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; C PEPTIDE; GLUCAGON; INSULIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RELEASE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET ALPHA CELL; PRIORITY JOURNAL; BLOOD; DIET RESTRICTION; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HISPANIC; METABOLISM; PHYSIOLOGY;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLUCAGON; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; INSULIN; MALE; MEXICAN AMERICANS;

EID: 34249858600     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-1515     Document Type: Article

References (42)

1. Rossetti L, Giaccari A, DeFronzo RA 1990 Glucose toxicity. Diabetes Care 13:610-630
2. Scarlett JA, Gray RS, Griffin J, Olefsky JM, Kolterman OG 1982 Insulin treatment reverses the insulin resistance of type II diabetes mellitus. Diabetes Care 5:353-363
3. Rossetti L, Smith D, Shulman GI, Papachristou D, DeFronzo RA 1987 Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin. J Clin Invest 79:1510-1515
4. Leahy JL, Bonner-Weir S, Weir GC 1988 Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy. J Clin Invest 81:1407-1414
5. Robertson RP, Olson IK, Zhang HJ 1994 Differentiating glucose toxicity from glucose desensitization: a new message from the insulin gene. Diabetes 43:1085-1089
6. Rossetti L, Shulman GI, Zawalich W, DeFronzo RA 1987 Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats. J Clin Invest 80:1037-1044
7. Leahy JL, Cooper HE, Deal DA, Weir GC 1986 Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusion. J Clin Invest 77:908-915
8. Kim JK, Zisman A, Fillmore JJ, Peroni OD, Kotani K, Perret P, Zong H, Dong J, Kahn CR, Kahn BB, Shulman GI 2001 Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4. J Clin Invest 108:153-160
9. Matsuda M, DeFronzo RA 1999 Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462-1470
10. Jiang G, Zhang BB 2003 Glucagon and regulation of glucose metabolism. Am J Physiol Endocrinol Metab 284:E671-E678
11. Cherrington AD 1999 Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. Diabetes 48:1198-1214
12. Gerich JE, Charles MA, Grodsky GM 1976 Regulation of pancreatic insulin and glucagon secretion. Annu Rev Physiol 38:353-388
13. Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, DeFronzo RA 2004 San Antonio metabolism study. β-Cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia 47:31-39
14. Reaven GM, Chen YD, Golay A, Swislocki AL, Jaspan JB 1987 Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 64:106-110
15. Larsson H, Ahren B 2000 Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance. Diabetes Care 23:650-657
16. Muller WA, Faloona GR, Aguilar-Parada E, Unger RH 1970 Abnormal α-cell function in diabetes. Response to carbohydrate and protein ingestion. N Engl J Med 283:109-115
17. Dimitriadis GD, Pehling GB, Gerich JE 1985 Abnormal glucose modulation of islet α- and β-cell responses to arginine in non-insulin-dependent diabetes mellitus. Diabetes 34:541-547
18. Baron AD, Schaeffer L, Shragg P, Kolterman OG 1987 Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics. Diabetes 36:274-283
19. Larsson H, Ahren B 2000 Glucose intolerance is predicted by low insulin secretion and high glucagon secretion: outcome of a prospective study in postmenopausal Caucasian women. Diabetologia 43:194-202
20. Shah P, Basu A, Basu R, Rizza R 1999 Impact of lack of suppression of glucagon on glucose tolerance in humans. Am J Physiol 277:E283-E290
21. Shah P, Vella A, Basu A, Basu R, Schwenk WF, Rizza RA 2000 Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab 85:4053-4059
22. DeFronzo RA, Ferrannini E, Simonson DC 1989 Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38:387-395
23. Muller WA, Faloona GR, Unger RH 1971 The effect of experimental insulin deficiency on glucagon secretion. J Clin Invest 50:1992-1999
24. Starke A, Grundy S, McGarry JD, Unger RH 1985 Correction of hyperglycemia with phloridzin restores the glucagon response to glucose in insulindeficient dogs: implications for human diabetes. Proc Natl Acad Sci USA 82:1544-1546
25. Ahren B, Larsson H 2001 Impaired glucose tolerance (IGT) is associated with reduced insulin-induced suppression of glucagon concentrations. Diabetologia 44:1998-2003
26. Greenbaum CJ, Havel PJ, Taborsky Jr GJ, Klaff LJ 1991 Intra-islet insulin permits glucose to directly suppress pancreatic A cell function. J Clin Invest 88:767-773
27. Samols E, Stagner JI, Ewart RB, Marks V 1988 The order of islet microvascular cellular perfusion is B - A - D in the perfused rat pancreas. J Clin Invest 82:350-353
28. Hamaguchi T, Fukushima H, Uehara M, Wada S, Shirotani T, Kishikawa H, Ichinose K, Yamaguchi K, Shichiri M 1991 Abnormal glucagon response to arginine and its normalization in obese hyperinsulinaemic patients with glucose intolerance: importance of insulin action on pancreatic α-cells. Diabetologia 34:801-806
29. 1997 Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197
30. Unger RH 1985 Glucagon physiology and pathophysiology in the light of new advances. Diabetologia 28:574-578
31. Olsen HL, Theander S, Bokvist K, Buschard K, Wollheim CB, Gromada J 2005 Glucose stimulates glucagon release in single rat α-cells by mechanisms that mirror the stimulus-secretion coupling in β-cells. Endocrinology 146:4861-4870
32. Wendt A, Birnir B, Buschard K, Gromada J, Salehi A, Sewing S, Rorsman P, Braun M 2004 Glucose inhibition of glucagon secretion from rat α-cells is mediated by GABA released from neighboring β-cells. Diabetes 53:1038-1045
33. Ostenson CG, Nylen A, Grill V, Gutniak M, Efendic S 1986 Sulfonylurea-induced inhibition of glucagon secretion from the perfused rat pancreas: evidence for a direct, non-paracrine effect. Diabetologia 29:861-867
34. Franklin I, Gromada J, Gjinoveri A, Theander S, Wollheim CB 2005 β-Cell secretory products activate α-cell ATP-dependent potassium channels to inhibit glucagon release. Diabetes 54:1808-1815
35. ATP channel sensitivity to adenosine 5′-triphosphate inhibition. Endocrinology 147:2155-2162
36. Ravier MA, Rutter GA 2005 Glucose or insulin, but not zinc ions, inhibit glucagon secretion from mouse pancreatic α-cells. Diabetes 54:1789-1797
37. + channels. J Physiol 528:509-529
38. ++ concentration oscillatory patterns in identified α- and β-cells within intact human islets of Langerhans. Diabetes 55:2463-2469
39. Stagner JI, Samols E, Weir GC 1980 Sustained oscillations of insulin, glucagon, and somatostatin from the isolated canine pancreas during exposure to a constant glucose concentration. J Clin Invest 65:939-942
40. Gromada J, Høy M, Buschard K, Rorsman P 2001 Somatostatin inhibits exocytosis in rat pancreatic α-cells by Gi2-dependent activation of calcineurin and depriming of secretory granules. J Physiol 535:519-532
41. Cejvan K, Coy DH, Efendic S 2003 Intra-islet somatostatin regulates glucagon release via type 2 somatostatin receptors in rats. Diabetes 52:1176-1181
42. Ishihara H, Maechler P, Gjinovci A, Herrera PL, Wollheim CB 2003 Islet β-cell secretion determines glucagon release from neighbouring α-cells. Nat Cell Biol 5:330-335